Aortech International PLC
24 July 2007
24 July 2007
AorTech International plc (the 'Company')
Directors' Dealing
Pursuant to a placing of 1,000,000 ordinary shares in the Company (the
'Placing') which was conditionally announced by the Company today, Dr Stuart
Rollason has conditionally subscribed for 8,825 Placing Shares, at a price of
510p each, representing 0.18 per cent of the issued share capital of the Company
following the Placing.
Dr Stuart Rollason is also a Partner of Bluehone Investors LLP, who immediately
prior to the Placing hold approximately 24.82 per cent. of the Company's current
issued share capital. As part of the Placing, Bluehone Investors LLP has agreed
to subscribe for 50,000 Placing Shares at a price of 510p each, representing
5.00 per cent. of the Placing Shares and as a result of the Placing will hold
approximately 20.7 per cent of the Company's issued share capital.
For further information please contact:
AorTech International plc Tel: + 1 801 201 4336
Frank Maguire, Chief Executive
Evolution Securities
Bobbie Hilliam Tel: +44 20 7071 4300
Tim Worlledge
Hogarth Partnership Limited Tel: +44 20 7357 9477
Melanie Toyne-Sewell
Sarah Richardson
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.